Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 14 September 2026.

Announcements

2,177

Total raised

£9.5B

disclosed amounts

This month

£14.4M

raised so far

Seed
£1.3M

The private investment round was led by David Brownlow and Ben Rawson of Havisham Group.

"It was clear right from introducing David to our platform that he understood the value of what we’re creating, and matched our ambition to bring something entirely new to the market. Having someone of David’s calibre and experience will be invaluable as we expand into North America, and Asia Pacific this year."
— Craig Unsworth, Group CEO
Seed
£350K

Swansea start-up QuoteOnSite secures seed capital from the Development Bank of Wales and Deri Green to scale its quote management platform.

"The investment has enabled us to now work full-time on QuoteOnSite and grow a team around us tomake the product the best it can be. We’re now starting to get traction in the market with a solid sales and marketing strategy. Being located at the TechHub Swansea is allowing us to meet customers as well as providing a great working space. Having spent the last two years working on QuoteOnSite alongside full-time jobs and family life, Elaine and I are excited to be able to focus more fully on the business. We’re pleased our software and business plan have attracted the attention of venture capitalists and are delighted to have completed our first seed round."
— TJ Amas, Co-founder
Seed
£1.3M

The financing round was led by RT Capital Management alongside the Oxford Technology and Innovations EIS Fund.

"Over the last few years Zegami has been developing a cutting edge Visual Data Exploration platform to democratise data analytics, enabling people to make sense of the tsunami of data available today."
— Samuel Conway, Co-Founder and CEO
Seed
£1.2M

The seed round was led by Playfair Capital and will support product development and team expansion.

"Many people living with cancer feel isolated and unsupported, and traditional routes of delivering healthcare struggle to address these issues. It’s also imperative that we gather the necessary data to understand how cancer therapies affect not just survival, but quality of life, so that patients and doctors can weigh up this information to make informed decisions about their care. At Vine, our goal is to put patients back in control."
— Rayna Patel, CEO